Skip to content
10-Q

Quarterly Report

MEDTOX SCIENTIFIC INC

0000739944-12-000023

← back to feed
Filed
Apr 26, 2012 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · Apr 12, 2012 8.97M sh
Shares Diluted Q1 2012 · Mar 31, 2012 9.07M sh
Shares Diluted Q1 2012 · Mar 31, 2011 9.04M sh
Capex Q1 2012 · Mar 31, 2012 $988K
Capex Q1 2012 · Mar 31, 2011 $1.13M
Operating Cash Flow Q1 2012 · Mar 31, 2012 $2.74M
Operating Cash Flow Q1 2012 · Mar 31, 2011 $1.3M
Cash And Equivalents Q1 2012 · Mar 31, 2012 $7.05M
Cash And Equivalents Q1 2012 · Dec 31, 2011 $5.27M
Cash And Equivalents Q1 2012 · Mar 31, 2011 $1.03M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $1.29M
Stockholders Equity Q1 2012 · Mar 31, 2012 $59.22M
Stockholders Equity Q1 2012 · Dec 31, 2011 $57.63M
Total Liabilities Q1 2012 · Mar 31, 2012 $13.12M
Total Liabilities Q1 2012 · Dec 31, 2011 $12.73M
Current Assets Q1 2012 · Mar 31, 2012 $34.67M
Current Assets Q1 2012 · Dec 31, 2011 $31.53M
Total Assets Q1 2012 · Mar 31, 2012 $79M
Total Assets Q1 2012 · Dec 31, 2011 $76.85M
Eps Diluted Q1 2012 · Mar 31, 2012 $0.17
Eps Diluted Q1 2012 · Mar 31, 2011 $0.09
Eps Basic Q1 2012 · Mar 31, 2012 $0.17
Eps Basic Q1 2012 · Mar 31, 2011 $0.09
Sga Expense Q1 2012 · Mar 31, 2012 $8.81M
Sga Expense restated Q1 2012 · Mar 31, 2011 $7.99M
Rd Expense Q1 2012 · Mar 31, 2012 $689K
Rd Expense Q1 2012 · Mar 31, 2011 $594K
Net Income Q1 2012 · Mar 31, 2012 $1.5M
Net Income Q1 2012 · Mar 31, 2011 $778K
Operating Income Q1 2012 · Mar 31, 2012 $2.36M
Operating Income Q1 2012 · Mar 31, 2011 $1.23M
Gross Profit Q1 2012 · Mar 31, 2012 $11.86M
Gross Profit restated Q1 2012 · Mar 31, 2011 $9.81M
Cost Of Revenue Q1 2012 · Mar 31, 2012 $16.72M
Cost Of Revenue Q1 2012 · Mar 31, 2011 $15.29M
Revenue Q1 2012 · Mar 31, 2012 $28.58M
Revenue restated Q1 2012 · Mar 31, 2011 $25.1M